Eleventh Annual Welcome Back Awards Program Honors Individuals who Positively Impact the Depression... ( -- Five Honorees will be recognized a...)

Eleventh Annual Welcome Back Awards Program Honors Individuals who Positively Impact the Depression Community

Date:5/15/2009

-- Five Honorees will be recognized at Ceremony in San Francisco --

INDIANAPOLIS, May 15 /PRNewswire-FirstCall/ -- After battling postpartum depression 13 years ago, Diana Lynn Barnes is an expert on the assessment and treatment of the disorder that threatened her life. Instead of pretending it never happened, Diana funneled the power of her survival into giving voice to other women experiencing the devastation of postpartum depression.

Diana is one of this year's five Welcome Back Award honorees who have overcome innumerable obstacles to make a profound difference in the lives of others. "Whether through producing a documentary about internal struggles, responding to a natural disaster that occurred half-way around the world, or implementing a screening program to identify women at risk for mood disorders during pregnancy, this year's honorees all make an outstanding effort at creating positive change for those with depression," said Dr. Carmen Vazquez Ph.D., clinical professor of psychiatry at New York University School of Medicine and the City University of New York, and Welcome Back Award committee member. "I am honored to be involved in giving these great individuals the recognition they deserve."

Eli Lilly and Company will be honoring these inspiring winners at the Eleventh Annual Welcome Back Awards ceremony in San Francisco, Calif. on Saturday, May 16. Lilly established the Welcome Back Awards in 1998 to fight the stigma associated with depression and to promote the understanding that depression is treatable. Each year, an independent panel of national mental health leaders recognizes five individuals for their outstanding achievements, and Lilly awards donations ranging between $10,000 and $15,000 to the not-for-profit organization of each winner's choice.

The 2009 Welcome Back Awards honorees a
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine news :

1. The Foundry Announces New Partners and Completion of Series A Financing for Eleventh Company
2. Abaxis, Inc. to Present at Needham & Companys Eleventh Annual Growth Stock Conference
3. Top Insurance Expert Calls on 144,000 Holders of Long-Term Care Polices to Protest an Eleventh Hour Conseco Trust
4. National Jewish Named the #1 Respiratory Hospital for the Eleventh Year in a Row
5. West Pharmaceutical Services to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
6. HealthSouth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference and the 2008 Credit Suisse Global Leveraged Finance Conference
7. Eleventh Annual Lehman Brothers Global Healthcare Conference to Webcast Millennium Presentation
8. Idenix Pharmaceuticals to Present at the Eleventh Annual Lehman Brothers Global Healthcare Conference
9. Johnson & Johnson to Participate in Lehman Brothers Eleventh Annual Global Healthcare Conference
10. Schering-Plough to Webcast Presentation by CEO Fred Hassan at Lehman Brothers Eleventh Annual Global Healthcare Conference
11. Gentiva(R) Health Services to Present March 18th at Lehman Brothers Eleventh Annual Global Healthcare Conference in Miami

Post Your Comments:

(Date:11/8/2009)...ssage of Health Care Reform Bill ,, Critical ...erage for all Americans ,, BALTIMORE, Nov. 7 /...nited States House of Representatives passed criti...ngthen Medicare for seniors and end discrimination...ericans out of affordable health coverage. ,, T...

(Date:11/7/2009)...Newswire-USNewswire/ -- Karen Ignagni, President a... released the following statement today on House p...support comprehensive health care reform, and we h...complete overhaul of how health insurance is provi...erage, elimination of pre-existing condition exclu...

(Date:11/7/2009)...wswire-USNewswire/ -- The American Medical Associa...ard for Citizenship and Community Service to Manus...IL. The award recognizes physicians who have gone ...o make an outstanding public service contribution ...ward today during the opening session of the 2009 ...

(Date:11/7/2009)...(CT), David A. Cook (GA), Louis J. Goodman (TX), P... ,, CHICAGO, Nov. 7 ...nted five medical society executive leaders with a...the goals and ideals of the medical profession. Th...olicy making meeting in Houston. ,, (Logo: h...

(Date:11/7/2009)...swire-USNewswire/ -- Members of the AMA are trying...solution rescinding the AMA,s support of HR 3962. ... responsible to their PATIENTS, not the leadership...icy for the Association of American Physicians and...other medical groups. ,, "If the AMA leadershi...

Breaking Medicine News(10 mins):Health News:AARP Maryland Key Vote News Alert 2 Health News:AARP Maryland Key Vote News Alert 3 Health News:AHIP Statement on House Passage of H.R. 3962 2 Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2 Health News:AMA Honors Medical Society Executives 2

[0] AARP Maryland Key Vote News Alert [0] AHIP Statement on House Passage of H.R. 3962 [0] AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members [0] AMA Honors Medical Society Executives [0] AMA Has Chance to Rescind Support of HR 3962; AMA Shout-Out from Public Urges Doctors to Answer to PATIENTS Not AMA Leadership

...m cells and their more committed kin, progenitor c...ability to produce different types of specialized ...r or replace damaged tissue holds great promise f...genitor cell? A team of researchers led by Berkele...

...., Feb. 27 Zimmer Holdings, Inc. (NYSE: ZMH ; S...utive Vice President and Chief Operating Officer o...d to its Board of Directors. Thermo Fisher Scient...are, and environmental, industrial and safety mark...

...rs note that exact in-flight medical emergency num...lthDay News) -- More than half of the medical emer...nting, a new study shows, but the researchers note...y data from 32 European airlines, although only fo...

...N, China, Feb. 27 /PRNewswire-Asia/ -- Winner Medi...Medical", the "Company"), a leading,manufacturer i...nd wound care,products), today announced that the ...by the patent: method for producing,spunlace non-w...

...h in Annual Net Sales Driven by Demand for Branded...m Operations, up 25% from 2007 , , - Provides 200..., CHADDS FORD, Pa., Feb. 27 Endo Pharmaceuticals ...ear ended December 31, 2008. , , Net sales for t...

..., ON, Feb. 27 /PRNewswire-FirstCall/ - Nuvo Resear...mpany focused on the research and development of d... skin using its topical and transdermal drug deliv...porate Developments:, - Presented positive Ph...

Cell microenvironments hold key to future stem cell therapies Zimmer Holdings Names Marc Casper to Board of Directors Fainting Most Common Medical Crisis on Planes Winner Medical Receives European Patent Office Approval for PurCotton(TM) Production Method Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results Nuvo announces 2008 fourth quarter and year-end financial results

(Date:11/6/2009)... 6 Keryx Biopharmaceutic...call on Tuesday, November 10, 2009 at 8:30 a.m. ES...lts and business outlook for the remainder of 2009...pany, will host the call. Keryx will announce its...ase to be issued prior to the call. ,, In order...

(Date:11/6/2009)...6 Caraco Pharmaceutical ... ketorolac tromethamine ophthalmic solution, 0.5% ...ug Administration (FDA) for Sun Pharma,s Abbreviat...#174; opthalmic solution on the first day followin... therapeutically equivalent to Acular® Ophtha...

(Date:11/5/2009)..., Calif., Nov. 5 Transce...alty pharmaceutical company focused on the develop... that address important therapeutic needs in the f... a webcast and teleconference with management to d...rsday, November 12, 2009, at 5:00 p.m. Eastern Sta...

Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2 Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2 Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2 Informex Rebrands Into Separate Pharmaceutical and Specialty Chemical Segments to Better Serve Exhibitors and Attendees 13190 1 Informex Rebrands Into Separate Pharmaceutical and Specialty Chemical Segments to Better Serve Exhibitors and Attendees 13190 2 Informex Rebrands Into Separate Pharmaceutical and Specialty Chemical Segments to Better Serve Exhibitors and Attendees 13190 3 San Francisco Bay Area Affiliate of the Susan G Komen for the Cure Funds Over 241 2 Million This Year to Community Outreach Programs 52668 1 San Francisco Bay Area Affiliate of the Susan G Komen for the Cure Funds Over 241 2 Million This Year to Community Outreach Programs 52668 2 San Francisco Bay Area Affiliate of the Susan G Komen for the Cure Funds Over 241 2 Million This Year to Community Outreach Programs 52668 3 San Francisco Bay Area Affiliate of the Susan G Komen for the Cure Funds Over 241 2 Million This Year to Community Outreach Programs 52668 4 Babies Can Comprehend Canine Language 52664 1 Babies Can Comprehend Canine Language 52664 2

[0] Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST [0] Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution [0] Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12

.../ -- Sugammadex -,the novel selective relaxant bin...human healthcare business unit of Akzo Nobel -,dem...s faster,reversal of neuromuscular blockade as com...rative residual curarization (PORC) or,re-occurren...s,pivotal Aurora trial were presented today at the...

...7 - Geron,Corporation,s (Nasdaq:GERN) telomerase i...od pharmacokinetics and tolerability in,its ongoin...,lymphocytic leukemia (CLL), according to data pre...ompany,s president, oncology, at,the Pan Pacific L...rmacokinetics; Pharmacodynamics Consistent with,Ex...

Other Medicine Technology:Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial as Compared to Neostigmine 2 Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial as Compared to Neostigmine 3 Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial as Compared to Neostigmine 4 Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good,Pharmacokinetics and Tolerability in Phase I/II Trial 2 Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good,Pharmacokinetics and Tolerability in Phase I/II Trial 3 Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good,Pharmacokinetics and Tolerability in Phase I/II Trial 4

Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial as Compared to Neostigmine Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good,Pharmacokinetics and Tolerability in Phase I/II Trial

Bateman Rongeur

Sundt Slim-Line Temporary Aneurysm Clip

Micro Needle Holders With Lock

Vascular Clamps B-3

Medicine Products:

Bateman Rongeur Sundt Slim-Line Temporary Aneurysm Clip Micro Needle Holders With Lock Vascular Clamps B-3

Eleventh Annual Welcome Back Awards Program Honors Individuals who Positively Impact the Depression...( -- Five Honorees will be recognized a...),Health